End-of-life treatment in managed care. The potential and the peril.
作者信息
Miles S H, Weber E P, Koepp R
机构信息
Center for Biomedical Ethics, University of Minnesota, Minneapolis 55414, USA.
出版信息
West J Med. 1995 Sep;163(3):302-5.
Abstract
摘要
相似文献
1
End-of-life treatment in managed care. The potential and the peril.管理式医疗中的临终治疗。潜力与风险。
West J Med. 1995 Sep;163(3):302-5.
2
Justice and managed care. Four principles for the just allocation of health care resources.
Hastings Cent Rep. 2000 May-Jun;30(3):8-16.
3
Hospice in a managed care environment: an integrated team approach.管理式医疗环境中的临终关怀：一种综合团队方法。
Health Care Innov. 1995 May-Jun;5(2):35-40.
4
Managed care and the threat to the patient-physician relationship.
Trends Health Care Law Ethics. 1995 Winter-Spring;10(1-2):19-24.
5
Paying physicians more to do less: financial incentives to limit care.给医生支付更多报酬却让他们减少工作量：限制医疗服务的经济激励措施。
Univ Richmond Law Rev. 1996 Jan;30(1):155-97.
6
APA resource document: I. The professional responsibilities of psychiatrists in evolving health care systems.美国心理学会资源文件：一、精神科医生在不断发展的医疗保健系统中的专业职责。
Bull Am Acad Psychiatry Law. 1996;24(3):393-406.
7
Managed care and ethics: a Jewish perspective.
Shma. 1996 Dec 27;27(524):5-7.
8
Managed care: "new moves," moral uncertainty, and a radical attitude.管理式医疗：“新举措”、道德不确定性与激进态度。
J Clin Ethics. 1995 Winter;6(4):290-305.
9
Managed care: an ethical reflection.管理式医疗：伦理思考。
Christ Century. 1998;115(22):748-51.
10
Health care in America: your money or your life.美国的医疗保健：要钱还是要命。
Economist. 1998;346(8058):23-24, 26.
引用本文的文献
1
Service use at the end-of-life in Medicare advantage versus traditional Medicare.医疗保险优势计划与传统医疗保险在生命末期的服务利用。
Med Care. 2013 Oct;51(10):931-7. doi: 10.1097/MLR.0b013e3182a50278.
2
Medicaid TEFRA option in Minnesota: implications for patient rights.明尼苏达州的医疗补助 TEFRA 选项：对患者权利的影响。
Health Care Financ Rev. 1999 Fall;21(1):65-78.
3
The ethical importance of differences between managed care systems.
HEC Forum. 1997 Dec;9(4):313-22. doi: 10.1023/a:1008895520062.
本文引用的文献
1
Economic appraisal in health care with particular reference to hospice and palliative care.
Aust Health Rev. 1989;12(2):72-6.
2
The role of economics in the evaluation of hospice care.
Health Policy. 1989 Oct;13(1):19-34. doi: 10.1016/0168-8510(89)90108-5.
3
Cost differences between hospice and nonhospice care. A comparison of insurer payments and provider charges.临终关怀与非临终关怀护理的成本差异。保险公司支付与医疗机构收费的比较。
Eval Health Prof. 1989 Jun;12(2):159-78. doi: 10.1177/016327878901200203.
4
Study: Hospice care can yield savings to HMOs, patients.研究表明：临终关怀可为健康维护组织和患者节省费用。
Healthc Financ Manage. 1991 Aug;45(8):84, 86.
5
Discussion of preferences for life-sustaining care by persons with AIDS. Predictors of failure in patient-physician communication.艾滋病患者对维持生命治疗的偏好探讨。医患沟通失败的预测因素。
Arch Intern Med. 1993 May 24;153(10):1241-8.
6
High-tech, aggressive palliative care: in the service of quality of life.高科技、积极的姑息治疗：为提高生活质量服务。
J Palliat Care. 1993 Spring;9(1):37-41.
7
Advance directives and the elderly: a study of intervention strategies to increase use.预立医疗指示与老年人：一项关于增加其使用的干预策略的研究
Gerontologist. 1993 Jun;33(3):342-9. doi: 10.1093/geront/33.3.342.
8
The economics of dying. The illusion of cost savings at the end of life.临终经济学。临终时成本节约的错觉。
N Engl J Med. 1994 Feb 24;330(8):540-4. doi: 10.1056/NEJM199402243300806.
9
Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer.保险公司对乳腺癌自体骨髓移植保险范围批准情况的差异。
N Engl J Med. 1994 Feb 17;330(7):473-7. doi: 10.1056/NEJM199402173300707.
10
Increasing the completion of the durable power of attorney for health care. A randomized, controlled trial.提高医疗保健持久授权书的签署率。一项随机对照试验。
JAMA. 1994 Jan 19;271(3):209-12.
Zotero 插件